PF-07054894

DRUG3 trials

Sponsors

Pfizer

Conditions

HealthyUlcerative Colitis

Phase 1

Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants

CompletedNCT04388878

Start: 2020-07-27End: 2022-06-21Updated: 2022-07-12

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

TerminatedNCT05549323

PfizerUlcerative Colitis

Start: 2022-11-07End: 2025-11-11Updated: 2026-02-25

A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body

CompletedNCT07009353

Start: 2025-06-20End: 2025-09-11Updated: 2025-12-02